STING1 and pancreatic adenocarcinoma: In this paper, we presented that with use of several human pancreatic adenocarcinoma cell lines, cell lines with defects in the STING pathway still have relatively low susceptibility to C-REV, while the other cell lines with a responsive STING pathway have relatively high susceptibility to C-REV.